Key result
Deep sedation using propofol for percutaneous mitral valve repair was as safe and effective as general anaesthesia, with a 0% conversion rate and reduced hospital stay.
Why the study?
Does deep sedation using propofol improve safety and reduce complications compared to general anaesthesia in high-risk patients undergoing percutaneous mitral valve repair?
RCT (n=21)
Open-label
randomized
Does deep sedation using propofol improve safety and reduce complications compared to general anaesthesia in high-risk patients undergoing percutaneous mitral valve repair?
Deep sedation is a safe and effective alternative to general anaesthesia for high-risk patients undergoing percutaneous mitral valve repair, potentially avoiding anaesthesia-related complications and shortening hospital stays.
Supports deep sedation with propofol to minimize general anesthesia risks in percutaneous mitral valve repair; extends RCT evidence for procedural sedation options.
OBJECTIVE: To characterize the safety and efficacy of deep sedation (DS) as compared to general anaesthesia (GA) in percutaneous mitral valve repair (PMVR) using the MitraClip system. BACKGROUND: PMVR with the MitraClip system has emerged as a therapeutic alternative to surgical valve repair in high-risk patients. The PMVR procedure is typically performed under GA. Due to their high surgical risk, avoidance of GA in many of those patients would be desirable. METHODS: In an open-label observational study 21 patients with severe mitral regurgitation were randomized to either GA or DS using propofol. Primary endpoints of this comparison were related to safety with rate of conversion from DS to GA, bleeding, aspiration, and pneumonia. Secondary endpoints were related to efficacy with procedural, in-hospital, and mid-term outcome at 1 month. RESULTS: All clips have been implanted successfully in both groups. No conversion from DS to GA was necessary. Four patients undergoing GA suffered from upper respiratory tract infections and two from peripheral vascular complications during placement of central venous catheter for GA. Short- and mid-term efficacy were comparable in both groups with a reduced hospital stay in the DS group. CONCLUSION: PVMR in high-risk patients performed under DS is as safe and effective as with GA, preventing complications related to GA and shortening hospital stay.
No takes yet. Share an insight, caveat, or question.
Rassaf et al. (2014) conducted an RCT in Severe mitral regurgitation (n=21). Deep sedation using propofol vs. General anaesthesia was evaluated on Safety (rate of conversion from deep sedation to general anaesthesia, bleeding, aspiration, and pneumonia). Deep sedation using propofol for percutaneous mitral valve repair was as safe and effective as general anaesthesia, with a 0% conversion rate and reduced hospital stay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: